(Report updated. See 2010 report on Ablation Technologies Worldwide.) The global market for medical devices is $200 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over [...]
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities · 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125 This report is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, [...]
Energy-based technologies and treatments exist for virtually all clinical specialties. Given the ability of these technologies, particularly ablation technologies, to very precisely destroy tissue, they have been strongly developed for cancer applications and much success has already been achieved in producing treatments that have low risk, short recovery times and good long term outcomes. Cost [...]
Manufacturers of ablation and other energy-base therapeutics are both witnessing and driving a steady evolution of multiple technologies with potential to produce therapeutic (or, in some cases, simply cosmetic) tissue effects, with different energy types competing head-on for caseload. These innovators have continued to improve their understanding of the nature of each energy type’s impact [...]
The world market for energy-based devices was well in excess of $25 billion in 2008. This represents almost 14% of the total medical device market; however, the share varies from country to country, since ablation therapy is high-technology and fairly high-cost; in poorer economies low-cost medical products such as syringes and consumables account for a [...]
Energy-based therapeutics include technologies to effect the destruction or treatment of tissues to remove pathology or otherwise modify tissue (e.g., for creating lesions that block the aberrant signals in arrhythmia). These technologies include radiofrequency, microwave, laser/light, microwave, cryo, hydromechanical, ultrasound and thermal. Some sectors of the energy-based market are growing steadily, others more rapidly. RF [...]
The worldwide high energy therapies market represents a $25 billion opportunity in 2008. The category consists of therapeutic devices and equipment that deliver the controlled application of one or more modalities of energy to tissue. The market will grow at an aggressive rate through 2017 for all modalities, but with some modalities exceeding compound annual [...]
Ultrasonic surgical systems deliver vibrational energy to ablate tissue and affect hemostasis. Unlike radiofrequency (RF) and laser systems that achieve coagulation through thermal welding, ultrasonic energy is not reliant upon heat to seal tissue. The popularity of ultrasonic systems is being driven by several inherent advantages. The absence of smoke, which improves the visual field [...]
Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial. Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective [...]
The global market for medical devices is currently a $185 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over a 600° C temperature range of -200° [...]
Contact:
